Bio-FD&C Co

Bio-FD&C Co OCF/Debt

The Operating Cash Flow to Debt Ratio of Bio-FD&C Co (251120.KQ) as of Oct 22, 2026 is 469.99 %. In the previous year, Operating Cash Flow to Debt Ratio was 502.63 % — a change of -6.49% (lower).

OCF/Debt

469.99 %

YoY

-6.49%

Last updated:

Operating Cash Flow to Debt Ratio of Bio-FD&C Co is 2024 469.99 % . Operating Cash Flow to Debt Ratio of Bio-FD&C Co was 2023 502.63 % . It decreases by -6.49% lower compared to the previous year.

The Bio-FD&C Co OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2018
42.06 KRW
Jan 1, 2019
121.76 KRW
Jan 1, 2020
87.10 KRW
Jan 1, 2021
216.87 KRW
Jan 1, 2022
179.78 KRW
Jan 1, 2023
502.63 KRW
Jan 1, 2024
469.99 KRW
The Bio-FD&C Co OCF/Debt history
YEAROCF/DebtYoY
469.99 %-6.49%
502.63 %+179.58%
179.78 %-17.10%
216.87 %+149.00%
87.10 %-28.47%
121.76 %+189.46%
42.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Operating Cash Flow to Debt Ratio of Bio-FD&C Co is 469.99 % in 2024.

Operating Cash Flow to Debt Ratio of Bio-FD&C Co changed from 502.63 % to 469.99 %, representing a -6.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Bio-FD&C Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Bio-FD&C Co

All Key Metrics — Bio-FD&C Co